cit | Article | January/February 2014
cit | News | February 9, 2010
cit | News | January 7, 2010
COMPARE Trial Supports Everolimus-Eluting DES Versus Paclitaxel-Eluting DES
January 8, 2010—Elvin Kedhi, MD, et al have published findings from the COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) trial online ahead of print in The Lancet.
cit | News | October 14, 2020
Combined FFR and OCT Imaging Studied to Identify High-Risk Lesions in Patients With Diabetes
October 14, 2020—The COMBINE (OCT-FFR) study found that the use of fractional flow reserve (FFR) combined with optical coherence tomography (OCT) imaging can help improve the accuracy of high-risk lesion identification in patients with diabetes.